Cargando…
A prospective multicenter study on genome wide associations to ranibizumab treatment outcome for age-related macular degeneration
We conducted a genome-wide association study (GWAS) on the outcome of anti-VEGF treatment for exudative age-related macular degeneration (AMD) in a prospective cohort. Four hundred and sixty-one treatment-naïve AMD patients were recruited at 13 clinical centers and all patients were treated with 3 m...
Ejemplares similares
-
Retinal pigment epithelial atrophy over polypoidal choroidal vasculopathy lesions during ranibizumab monotherapy
por: Hikichi, Taiichi, et al.
Publicado: (2016) -
Intraoperative endoscopic observation of sclerotomy site after cannula removal for 23-gauge vitrectomy
por: Hikichi, Taiichi, et al.
Publicado: (2014) -
Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration
por: Tsuchihashi, Takashi, et al.
Publicado: (2014) -
Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy
por: Hikichi, Taiichi, et al.
Publicado: (2013) -
Two-year outcomes of intravitreal bevacizumab therapy for macular oedema secondary to branch retinal vein occlusion
por: Hikichi, Taiichi, et al.
Publicado: (2014)